Modulation of the Cellular Phenotype in Human Colon Adenocarcinoma Cells by Folic Acid and Polyamine Pools Nathan W. Sweeney, Julie A. Buckmeier, Christina.

Slides:



Advertisements
Similar presentations
Biology of cultured cells conti- Part 4 By : Saib al owini.
Advertisements

p53 Revealed character as a tumor suppressor gene in 1989.
Carcinogenesis Stages & Mechanisms. Eva Szabo & Gail L. Shaw
Effects of Etoposide on the Apoptosis of HL-60 Cells Stefanos F. Haddad a, Glaucia V. Faheina-Martins b,c, Demetrius A. M. Araújo b,c a Department of Biology,
Lecture #8Date _________ n Chapter 19~ The Organization and Control of Eukaryotic Genomes.
1. What is the Central Dogma? 2. How does prokaryotic DNA compare to eukaryotic DNA? 3. How is DNA organized in eukaryotic cells?
INTERPLAY OF POLYMER AND NUCLEIC ACID PROPERTIES ON EFFECTIVENESS OF ANTISENSE OLIGONUCLEOTIDES Antisense oligonucleotides present a potentially powerful.
Increased K-Ras Protein and Activity in Mouse and Human Lung Epithelial Cells at Confluence Cell Growth and Differentiation Vol. 13, , September.
The Fusarium toxin Enniatin exerts p53- dependent cytostatic and p53-independent cytotoxic activities against human cancer cells R. Dornetshuber a, P.
KRAS testing in colorectal cancer: an overview. 2 What is KRAS? KRAS is a gene that encodes one of the proteins in the epidermal growth factor receptor.
Proteins, Mutations and Genetic Disorders. What you should know One gene, many proteins as a result of RNA splicing and post translational modification.
Inhibition of SHH signaling enhances Docetaxel efficacy in castration-resistant prostate cancer cells Sierra L. Lawhorne 1,2, Sakthivel Muniyan 1, Parthasarathy.
Signaling Pathways Produced By Combining DsRNA with Paclitaxal to treat Ovarian Cancer Switu Patel.
Tumor genetics Minna Thullberg
Cellular Senescence: A Link between Tumor Suppression and Organismal Aging.
Oncogenes, Tumor Suppressors, and the Cell Cycle Radiobiology 2012.
Co-supervisor: Prof Richard Lock
Control of Gene Activity Chapter 17. Controlling gene activity Remember to control the cell one must control protein synthesis. Remember to control the.
SC121 Unit Three Karma Pace, MS AIM: kpacemcduffy.
Isosteviol derivatives induced apoptosis in Human lung cancer via targeting MEK/MAPK pathway: An in vitro and in vivo study Ahmed M Malki 1,,PhD Stephen.
Group Number: 2 Britney Porter, Sandra Nguyen, Eduardo Vargas and Samender Singh Randhawa.
Characteristics of Cancer. Promotion (reversible) Initiation (irreversible) malignant metastases More mutations Progression (irreversible)
Doreen Asiimwe Buhwa 1, Philip Magambo 1, Julius Mulindwa 2, Stephen Ochaya 3, Bjorn Anderson 3, Anne Kazibwe 1, Enock Matovu 1 1 College of Veterinary.
1. p53 Structure, Function and Therapeutic Applications Provider: Dr.Davood Nourabadi(PhD,medical physiology) mdphysiology.persianblog.ir.
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment Schafer ZT, Grassian AR, Song L, Jiang Z, Gerhart-Hines Z, Irie.
Acknowledgement of funding Regulator of G-protein signaling 5 blunts cellular viability mediated by a stabilized lysophosphatidic acid analogue (2S-OMPT)
SiRNA and Epigenetic Asma Siddique Saloom Aslam Syeda Zainab Ali.
Cancer and the Cell Cycle. Outline of the lecture n What is cancer? n Review of the cell cycle and regulation of cell growth n Which types of genes when.
P53 Missense Mutation Cancer. Outline Disease related to p53 Role and regulation pathway Structure of p53 Missense mutation and consequences Experiment’s.
Chapter 18. Transcription Operon Operon: cluster of related genes with on/off switch Three Parts: 1.Promoter – where RNA polymerase attaches 2.Operator.
HDAC6 : HDAC6 is a cytoplasmic enzyme that regulates many important biological processes. : HDAC6 has recently emerged as a tubulin deacetylase that has.
Benign Versus Malignant Tumors
Eukaryotic Gene Control. Gene Organization: Chromatin: Complex of DNA and Proteins Structure base on DNA packing.
Chromatin Structure:  Tightly bound DNA less accessible for transcription  DNA methylation: methyl groups added to DNA; tightly packed;  transcription.
Cancer Accelerated Biology. Learning Objectives The different methods of diagnosing cancer. The difference between a malignant tumor and a benign tumor.
Cell Biology Lec.5 Dr:Buthaina Al-Sabawi Date: Cell Biology Lec.5 Dr:Buthaina Al-Sabawi Date: The Cell Cycle The cell cycle, is the.
PROTEASOME INHIBITION AND NOT NF-ΚB INHIBITION INDUCES APOPTOSIS TO RESISTANT CELLS IN GLUCOCORTICOID-INDUCED APOPTOSIS George I Lambrou 1, Apostolos Zaravinos.
Cellular Senescence What is it? What causes it? Why is it important (cancer and aging)?
ONCOGENE AND ITS ROLE IN THE DEVELOPMENT OF LEUKAEMIA Nouf khaled al-Hajjar SUPERVISOR Dr.SAMINA HAQ.
Products > U87 Transfection Reagent (Glioblastoma Cells) Altogen Biosystems offers the U87 Transfection Reagent among a host of 100+ cell line specific.
Targeting of reactive oxygen species can be a potential therapeutic strategy for cancer treatment Ying-Ray Lee 1, San-Yuan Chen 2, and Hau-Ren Chen 3 1.
YEATS4 Is a Novel Oncogene Amplified in Non– Small Cell Lung Cancer That Regulates the p53 Pathway Speaker:Dai-Wei Hsuan Adviser:Dr. Guor-Mour, Her Data:2015/04/22.
Lactate dehydrogenase is crucial for tumor associated macrophage protection of multiple myeloma cells against chemotherapy Carolyn Stierhoff, Enguang Bi,
Biological activity of novel synthetic tylophorine analogs in MCF-7 breast cancer cells Przemysław Czajkowski 1, Edyta Andrulewicz 1, Anna Bielawska.
Molecular Genetics: Part 2B Regulation of metabolic pathways:
Volume 11, Issue 4, Pages (April 2007)
p53 function and regulation in normal cells and cancer cells
Eukaryote Regulation and Gene Expression
4- Protein identification
Regulation of Gene Expression
Marissa V. Powers, Paul A. Clarke, Paul Workman  Cancer Cell 
Volume 133, Issue 1, Pages (July 2007)
Marissa V. Powers, Paul A. Clarke, Paul Workman  Cancer Cell 
Notes: Regulating the Cell Cycle
Transcription Initiation:
Kimberley A. Beaumont, David S. Hill, Sheena M. Daignault, Goldie Y. L
The Human Immunodeficiency Virus Protease Inhibitor Ritonavir Inhibits Lung Cancer Cells, in Part, by Inhibition of Survivin  Anjaiah Srirangam, PhD,
BCL11B-Mediated Epigenetic Repression Is a Crucial Target for Histone Deacetylase Inhibitors in Cutaneous T-Cell Lymphoma  Wenjing Fu, Shengguo Yi, Lei.
Epigenetics modification
A novel class I histone deacetylase inhibitor, I-7ab,
Kellie J. White, Vincent J. Maffei, Marvin Newton-West, Robert A
A Genetic Screen Identifies TCF3/E2A and TRIAP1 as Pathway-Specific Regulators of the Cellular Response to p53 Activation  Zdenek Andrysik, Jihye Kim,
Yu-Fen Wang1, Ya-Chi Chan1, Dar-Ren Chen1, 2, Hui-Yi Lin3
Volume 9, Issue 3, Pages (September 2017)
Synthetic Lethal Screening Identifies Compounds Activating Iron-Dependent, Nonapoptotic Cell Death in Oncogenic-RAS-Harboring Cancer Cells  Wan Seok Yang,
UVB and Proinflammatory Cytokines Synergistically Activate TNF-α Production in Keratinocytes through Enhanced Gene Transcription  Muhammad M. Bashir,
BCL11B-Mediated Epigenetic Repression Is a Crucial Target for Histone Deacetylase Inhibitors in Cutaneous T-Cell Lymphoma  Wenjing Fu, Shengguo Yi, Lei.
Supplementary Figure 1 A B C SW620 HT29 SW620
Volume 4, Issue 1, Pages (July 2013)
Loyola Marymount University
Presentation transcript:

Modulation of the Cellular Phenotype in Human Colon Adenocarcinoma Cells by Folic Acid and Polyamine Pools Nathan W. Sweeney, Julie A. Buckmeier, Christina R. Preece, Patricia A. Thompson Cancer Biology Graduate Interdisciplinary Program, University of Arizona Cancer Center, Tucson, Arizona. Background Human colon adenocarcinoma is the most common type of gastrointestinal cancer and ranks third in occurrence and death in both males and females. Polyamines are small, positively charged molecules derived from endogenous biosynthesis or exogenous sources (diet, gut flora, cellular excretions). Polyamines have demonstrated to be involved in a large number of cellular processes such as receptor-ligand interactions, transcription, translation, DNA stabilization, cell growth, proliferation, and migration. Folate is a naturally occurring form of the water-soluble vitamin B9. Folic acid is a synthetic form of the vitamin used in fortified foods. Folic acid is crucial for proper brain function. As well as the synthesis, methylation and repair of DNA. Polyamines and Folic acid are required for both normal and cancer cell growth. Methods Cell Proliferation Assay: Treated human colon adenocarcinoma cell lines HCT116 and Caco2 with DFMO and/or MTX for 72 hours. DFMO uptake experiments: Cells were serum starved for 24 hours. Treated HCT116 cells with DFMO for 72 hours and approximately three doublings. Treated Caco2 cells with DFMO for 120 hours and approximately one doubling. Real Time PCR: HCT116 and Caco2 cells were treated with DFMO and/or MTX for 72 hours. Analyzed EGFR and KRT20 mRNA expression level in treated cells. Preliminary Results Questions 1.Difluoromethylornithine (DFMO), a cytostatic drug and effective inhibitor of polyamine production, alone is sufficient to arrest colon cancer cells but not induce senescence nor apoptosis. Methotrexate (MTX) is a cytotoxic drug capable of inhibiting folic acid. Therefore, will inhibition of both pools result in a complimentary effect? 2.Oncogene induced senescence (OIS) has been determined to be a form of tumor growth inhibition. What involvement does polyamine depletion have on preventing OIS? 3.DFMO, through polyamine depletion has shown to induce differentiation in cancer stem cells. Although the nature of the cell post treatment is unknown. Identification of the genes will reveal colon adenocarcinoma cell modulators. Figure 1. Overview of Polyamine and Folic Acid Pathways Summary of Preliminary Results: The cell proliferation assay revealed an IC50 for DFMO and MTX in HCT116 and Caco2 cell lines. DFMO uptake experiment indicated that DFMO requires cell division and that uptake occurs at approximately each estimated doubling time point. Real Time PCR revealed that treatment with DFMO and/or MTX modulates EGFR and KRT20 expression level in HCT116 and Caco2 cell lines. Results could demonstrate an induced differentiation initiated by DFMO. Discussion & Future Directions: Uncomplimentary effect of DFMO/MTX in combination during the cell proliferation assay leads us to believe an “either/or” result due to early cell cycle incorporation of DFMO and arrest preventing the incorporation of MTX and its cytotoxic effects. The DFMO treatment experiments indicated when drug is likely taken into the cell and that it is effective at each cell doubling. Flow cytometry will allow us to pinpoint at which cell cycle stage DFMO is active. Additionally, it seems prudent to utilize an agent that is not cell cycle dependent, in combination with DFMO, in order to perhaps achieve an enhanced or synergistic effect. Its been shown previously that cells treated with DFMO can be rescued. This rescue indicates that cells are temporally arrested and not in a permanent state of senescence. It’s thought that depletion of polyamines inhibits an oncogene induce senescence but the mechanisms are unknown and require investigation. Its been shown previously that DFMO can induce differentiation in cancer stem cells. KRT20 is an intermediate filament protein found in colonic epithelial cells and its 2-fold increased expression in Caco2 cells by DFMO may indicate a shift to a more differentiated phenotype. Further profiling of genes could potentially reveal colon adenocarcinoma cell modulators as well as targets. Figure 3. Effect of Serum Starvation and DFMO on Cellular Proliferation in HCT116 and Caco2 Cell Lines. Figure 2. Effect of DFMO and/or MTX on Cellular Proliferation in Human Colon Adenocarcinoma Cell Lines Figure 4. Differential Effect of DFMO and/or MTX on EGFR and KRT20 mRNA Expression in Human Colon Adenocarcinoma Cells Lines. Acknowledgements and Contact*: Thompson Lab CBIO Department Initiative for Maximizing Student Diversity (IMSD) Chahta Foundation & The Choctaw Nation of Oklahoma